NClip

Respiratory Viral Infections

6 min read

Respiratory Viral Infections

Key Points

  • Major respiratory viral illnesses include influenza, COVID-19, RSV, and rhinoviruses.
  • These infections commonly target respiratory epithelium, trigger inflammatory cascades, and can impair ventilation and gas exchange.
  • Core diagnostic tools include RT-PCR testing, with pathogen-specific adjunct tests such as influenza RIDTs, COVID-19 antigen tests, and RSV DFA testing.
  • Nursing priorities include oxygenation monitoring, symptom-directed support, infection-control precautions, and clear home-care teaching.
  • Evaluation focuses on measurable airway and oxygenation outcomes and timely care-plan revision when goals are only partially met.
  • RSV-related illness can be severe in young infants and high-risk clients, requiring early escalation planning.

Pathophysiology

Respiratory viral infections are caused by pathogens that enter through inhalation of respiratory secretions or contact with contaminated surfaces, then infect respiratory epithelial cells. Shared downstream effects include inflammation, tissue injury, and reduced respiratory efficiency.

  • Influenza: Infects respiratory epithelial cells and promotes cytokine-mediated inflammation.
  • COVID-19 (SARS-CoV-2): Targets ACE2-expressing cells and may trigger dysregulated inflammation with severe lower-respiratory involvement.
  • RSV: Infects ciliated epithelium and forms syncytia, increasing airway obstruction from inflammation and mucus; reinfection can recur because durable long-term immunity is limited.
  • Rhinoviruses: Common upper-respiratory pathogens, usually mild but potentially destabilizing in high-risk clients.

Nursing Assessment

NCLEX Focus

For respiratory viral illness, prioritize airway and oxygenation first, then match likely transmission route to correct precaution workflow.

Assessment should include multi-system symptom review, respiratory status trending, and early cue recognition of deterioration.

Body SystemCommon Findings Across Viral Respiratory Illnesses
GeneralFever, fatigue, body aches
RespiratoryCough, sore throat, congestion, dyspnea, wheeze
GastrointestinalNausea, vomiting, diarrhea (variable by pathogen)
NeurologicalHeadache; for COVID-19, loss of taste/smell and brain fog may occur
MusculoskeletalMyalgias and joint discomfort

Key nursing surveillance includes:

  • SpO2 trends and escalating oxygen needs
  • Work of breathing and breath-sound changes
  • Hydration status during fever and increased secretions
  • Ability to maintain social connection and coping during isolation
  • In premature infants or infants younger than 2 months, monitor closely for apnea as an early severe cue
  • In infants and high-risk children, watch for progression to bronchiolitis (rhonchi, wheeze, accessory-muscle use, prolonged expiration, fatigue)

Diagnostic Tests

Diagnostic testing identifies the causative virus and supports treatment and infection-control decisions.

  • Rapid antigen tests provide faster bedside results but are generally less sensitive than PCR-based tests.
  • PCR testing is more accurate and can detect multiple pathogens when a respiratory panel is used.
  • Chest X-ray may be used to evaluate pneumonia concern, though findings can be nonspecific.

Influenza

  • Rapid Influenza Diagnostic Tests (RIDTs): Fast antigen testing with lower sensitivity.
  • RT-PCR: Gold-standard molecular test for high sensitivity and subtype differentiation.
  • Viral culture: Less commonly used due to turnaround time; useful for characterization.

COVID-19

  • RT-PCR: Primary molecular diagnostic method.
  • Antigen tests: Faster but generally less sensitive than RT-PCR.
  • Antibody tests: Useful for prior exposure context, not primary active-infection diagnosis.

Respiratory Syncytial Virus (RSV)

  • RT-PCR: High sensitivity and specificity.
  • Direct fluorescent antibody (DFA) testing: Rapid antigen-focused option in select settings.

Rhinoviruses

  • RT-PCR: Preferred high-sensitivity molecular method.
  • Viral culture: Occasional use for isolation and characterization.

Nursing Diagnoses and Outcomes

Common nursing diagnoses include:

  • Ineffective airway clearance
  • Impaired gas exchange
  • Altered breathing pattern
  • Risk for social isolation
  • Risk for fluid volume deficit
  • Hyperthermia

Example measurable outcomes:

  • Client maintains a patent airway with reduced or absent audible secretions.
  • Client maintains oxygenation with stable SpO2 above 92% on room air or prescribed oxygen support.
  • In acute pediatric RSV pathways, client demonstrates improving oxygenation trend (often targeted at or above 95% when ordered in a time-bound goal).
  • Client demonstrates effective secretion-clearance techniques (for example deep breathing or incentive spirometry).
  • Client identifies practical methods to sustain social connection during isolation precautions.
  • Client maintains age-appropriate hydration indicators (moist mucosa, adequate urine output, normal/supported perfusion cues).

Nursing Interventions

Medical and Supportive Care Collaboration

  • Administer ordered antiviral agents when indicated (for example influenza or severe COVID-19 pathways).
  • Support etiology-targeted therapy when ordered (for example oseltamivir for influenza, remdesivir for selected COVID-19 pathways).
  • For severe RSV/viral distress, support escalation from supplemental oxygen to high-flow nasal cannula, CPAP, or invasive ventilation as ordered.
  • Support symptom-directed medication use (antipyretics, bronchodilators, corticosteroids when clinically indicated).
  • Assist with secretion management interventions such as nasal suctioning (including pre-feed suctioning in infants) and deep suctioning when ordered.
  • Support hydration delivery by tolerated route (oral, IV, or NG) to reduce dehydration and secretion thickening.
  • Escalate respiratory support as needed from supplemental oxygen to noninvasive or invasive ventilation support.
  • Encourage hydration and rest to support secretion management and recovery.
  • In RSV prevention pathways, coordinate ordered passive-immunity products for eligible infants/children.

Infection-Control Measures

  • Implement standard and transmission-based precautions based on suspected or confirmed route.
  • Reinforce hand hygiene, cough etiquette, and PPE use for clients and caregivers.
  • Match room placement and mask/respirator requirements to droplet, contact, or airborne workflows.
  • Reinforce visitor PPE adherence for close-contact caregiving during hospitalization (for example gown/mask per unit protocol).
  • Reinforce environmental disinfection and high-touch-surface cleaning in home and care settings.

Health Teaching

  • Teach symptom monitoring and when to seek urgent care.
  • Reinforce medication adherence and home symptom-management strategies.
  • Encourage effective coughing and deep-breathing exercises for secretion clearance.
  • Reinforce recommended vaccines (influenza, COVID-19, and RSV where indicated) as prevention strategy.
  • Teach caregivers to limit high-risk infant exposures during RSV season (for example avoid close-contact kissing/cuddling by symptomatic contacts).
  • Teach energy-conservation strategies in ill children (small frequent feeds, soothing to limit prolonged crying-related fatigue).

Evaluation and Care Plan Revision

Evaluation is ongoing and should occur after interventions, new diagnostic data, and interprofessional planning updates.

  • Determine whether expected outcomes are met, partially met, or not met within planned timeframes.
  • Revise the care plan promptly when outcomes are unmet or partially met.

Self-Check

  1. Which test is considered the gold standard for influenza diagnosis, and why?
  2. How do droplet, contact, and airborne precautions differ in routine bedside workflow?
  3. Which findings suggest a client with viral respiratory illness may be progressing toward respiratory failure?

Graph View

Backlinks